glp 1 epilepsy Could GLP-1 Drugs Lower Risk in People with Diabetes? A preliminary study of people

Nambi P, Basso MD, Chen L et al (2007) Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice

While they are highly effective for chronic weight management, GLP-1 peptides were initially developed to manage Type 2 Diabetes and also offer significant cardiovascular and other metabolic health benefits

J.LowP.HewittL

Efpeglenatide: originally developed by Sanofi, an exendin-4 analog with Fc fusion and PEGylation

Cost was not considered in the recommendations

But there are some caveats to understand about who can take them and the reality of what side effects can look like